Prev Arrow Stocks

Revvity ($RVTY) Stock Forecast: Up 5.3% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Revvity?

Revvity Inc (RVTY) is a health-sciences company that has been experiencing a mix of market movements recently. Despite a 5% jump in pre-market trading today, the stock has been down approximately 9% over the past year.

Why is Revvity going up?

RVTY stock is up 5.3% on Jan 13, 2026 19:01

  • Revvity's stock saw a strong bullish movement today, rising by 6.9% ahead of the U.S. stock market open.
  • The positive market response could be attributed to the company's recent guidance hike and exceeding the top-end of its EPS and revenue guidance, indicating stronger-than-expected financial performance.
  • Investors might be optimistic about Revvity's upcoming earnings report and the anticipated financial results, with revenue expectations for the fourth quarter and full year 2025 looking promising.
  • The presentation suggesting that existing end market trends will continue into 2026 could have also contributed to the bullish sentiment surrounding Revvity's stock today.

RVTY Price Chart

RVTY Technical Analysis

RVTY News

Revvity Inc Expect Existing End Market Trends To Continue Into 2026 - Presentation

Revvity Inc (RVTY) anticipates that current end market trends will persist into 2026, as indicated in a recent presentation. This news item provides only a headline and no further details regarding the company's outlook. The information is provided by Refinitiv and Reuters.

https://www.tradingview.com/news/reuters.com,2026:newsml_FWN3YE0KR:0-revvity-inc-expect-existing-end-market-trends-to-continue-into-2026-presentation/

0 News Article Image Revvity Inc Expect Existing End Market Trends To Continue Into 2026 - Presentation

S&P 500 Futures Decline in Premarket Trading; L3Harris Technologies, Revvity Lead

S&P 500 futures declined in premarket trading. L3Harris Technologies Inc. (LHX) saw a 13.0% increase, and Revvity Inc. (RVTY) rose by 6.9% ahead of the U.S. stock market open.

https://www.barrons.com/articles/s-p-500-futures-decline-in-premarket-trading-l3harris-technologies-revvity-lead-0c98e73b

1 News Article Image S&P 500 Futures Decline in Premarket Trading; L3Harris Technologies, Revvity Lead

Revvity Stock Jumps After Guidance Hike. Why the Shares Are at a Crossroads.

Revvity stock saw a 5% jump pre-market trading after the health-sciences company raised its full-year profit outlook. This guidance hike comes ahead of its earnings report due early next month. Despite this jump, the stock has been down approximately 9% over the past year.

https://www.barrons.com/articles/revvity-stock-jumps-profit-outlook-earnings-bf97c0de?gaa_at=eafs&gaa_n=AWEtsqeaZToEQ-kx9qY-XT2UWyOietNYBovX6OaSQPwGJ1JNJrScJNdk5vk6&gaa_ts=69662810&gaa_sig=L6gF9OK38PTWRWkEEgz_Cnd3D9ThtVw0vUZZb0OOqsQ-05fyIbG2nK1mAoYU9g4TxGKyGMmBNQjwnYhveYNwzg%3D%3D

2 News Article Image Revvity Stock Jumps After Guidance Hike. Why the Shares Are at a Crossroads.

Revvity Stock Pre-Market (+4.9%): Exceeds Top-End of EPS and Revenue Guidance

Revvity stock saw a pre-market increase of 4.9% after the company announced it exceeded the higher end of its EPS and revenue guidance. This positive performance indicates stronger-than-expected financial results for the company.

https://www.trefis.com/data/companies/RVTY/no-login-required/GVdit645/Revvity-Stock-Pre-Market-4-9-Exceeds-Top-End-of-EPS-and-Revenue-Guidance

3 News Article Image Revvity Stock Pre-Market (+4.9%): Exceeds Top-End of EPS and Revenue Guidance

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Revvity, Inc. will release its fourth quarter and full year 2025 financial results on Monday, February 2, 2026, followed by a conference call at 8:00 a.m. ET. The company anticipates fourth quarter revenue of approximately $772 million and full year 2025 revenue of around $2,855 million, with adjusted earnings per share expected to surpass previous guidance. Additionally, Prahlad Singh will present at the J.P. Morgan Healthcare Conference on January 13, 2026.

https://www.pharmiweb.com/press-release/2026-01-13-4/revvity-to-hold-earnings-call-on-monday-february-2-2026-provides-update-on-financial-performance

4 News Article Image Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

Revvity Price History

05.00.2026 - RVTY Stock was up 1.8%

  • The upward movement in RVTY's stock can be linked to the positive market sentiment surrounding its upcoming Q4 2025 earnings, with analysts forecasting an increase in adjusted EPS and a strong history of surprise earnings.
  • The notable increase in stake of Allspring Global Investments Holdings LLC by 14,741.7% in Q3, coupled with the company's stock buyback initiative and quarterly dividend declaration, likely bolstered investor confidence and contributed to the positive trend.
  • Moreover, the acquisition of RVTY shares by Diamond Hill Mid Cap Strategy in Q3, based on the company's undervaluation and enhanced product portfolio, may have further fueled optimism among traders, leading to the rise in the stock price.
  • In summary, positive earnings outlook, institutional investments, and strategic acquisitions have propelled RVTY's stock on an upward trajectory, reflecting investor confidence in the company's growth potential.

30.06.2025 - RVTY Stock was down 5.2%

  • Revvity exceeded expectations for Q2 earnings and revenue, indicating growth in the Diagnostics business and a rebound in Life Sciences sales, possibly boosting investor confidence.
  • The revision of FY25 EPS guidance due to challenges related to China DRG policy may have caused investor concerns and influenced the stock's bearish trend.
  • Despite consistently surpassing earnings estimates previously, uncertainties surrounding policy changes in key markets like China might have overshadowed the company's positive financial performance, contributing to the stock's decline.

22.03.2025 - RVTY Stock was up 5.1%

  • Regarding the current market movement of RVTY:
  • Investors may be looking at potential growth opportunities and recent strategic partnerships rather than the projected decline in Q1 earnings.
  • Speculation about a possible recovery in the following quarters could be sparking increased buying activity.
  • Positive market sentiment and broader industry trends might be influencing the stock's upward movement despite the anticipated drop in earnings.
  • Insider information or market rumors could potentially be contributing to the rise in stock price, disregarding the predicted earnings decrease.

04.10.2024 - RVTY Stock was up 3.0%

  • RVTY surpassed Q3 earnings and revenue estimates, showing strong financial performance.
  • The positive earnings surprise hints at solid performance in the Diagnostics segment.
  • Despite facing challenges in the Life Sciences segment, the overall performance exceeded expectations, prompting the stock's bullish movement.
  • Investor confidence in the company's future likely increased following the Q3 results.

13.00.2026 - RVTY Stock was up 7.7%

  • Revvity stock surged by 6.9% in premarket trading, following a 5% jump after the company raised its full-year profit outlook. This positive guidance hike ahead of the earnings report seems to have instilled confidence in investors.
  • The company exceeded the top-end of its EPS and revenue guidance, indicating robust financial performance. This unexpected positive news likely contributed to the bullish movement in the stock price.
  • With Revvity expecting to surpass its Q4 guidance with 6% revenue growth and adjusted earnings per share above previous estimates, investors are optimistic about the company's future financial health.
  • The upcoming earnings call on February 2, 2026, where Revvity will provide a detailed update on its financial performance, is anticipated to be a key event that investors are looking forward to, driving the bullish sentiment further.

06.00.2026 - RVTY Stock was up 5.4%

  • The introduction of Signals Xynthetica, the AI-augmented design platform, is believed to have instilled optimism among investors, leading to a rise in RVTY stock.
  • Analysts are expecting a positive Q4 2025 earnings statement, projecting an 8.5% increase in adjusted EPS, potentially enhancing investor trust in the company's future growth.
  • The notable rise in investment from Allspring Global Investments Holdings LLC, along with Revvity's stock repurchase program and dividend declaration, signifies robust investor interest and backing for Revvity's upcoming performance.
  • Although some caution exists due to high valuations and prior underperformance, the general market sentiment appears to have shifted positively towards Revvity, evident in the recent bullish activity.

23.06.2025 - RVTY Stock was up 7.1%

  • Revvity (RVTY) is expected to beat earnings estimates for the second quarter, as analysts are optimistic about its key metrics and overall performance.
  • The positive outlook and anticipation of a strong earnings report likely contributed to the bullish movement in Revvity's stock price today.
  • Investors are showing confidence in Revvity's potential for growth and profitability, driving the stock higher in anticipation of positive news from the upcoming earnings release.

03.03.2025 - RVTY Stock was down 5.1%

  • The recent approval of Revvity's Auto-Pure 2400 platform by the FDA for high-throughput latent TB testing is a positive development reflecting improved accuracy and efficiency in disease diagnosis and treatment.
  • Nevertheless, the market displayed a bearish reaction, potentially due to investors opting to secure profits after anticipating the FDA's approval.
  • Concerns regarding competition in healthcare technology or broader market circumstances impacting RVTY's stock price could also have influenced the bearish sentiment among investors.
  • Although the FDA approval marked a significant achievement for Revvity, short-term market forces and investor outlook likely contributed to the decline in RVTY stock value today.

22.06.2025 - RVTY Stock was up 5.1%

  • The bullish movement in RVTY's stock price could be attributed to the market's anticipation of a positive earnings report for the second quarter.
  • Investors seem optimistic about RVTY's ability to surpass earnings estimates, leading to increased buying activity and driving the stock price higher.
  • The positive outlook for RVTY reflects the market's confidence in the company's performance and growth prospects, positioning it as a favorable investment option in the tech sector.

13.00.2026 - RVTY Stock was up 5.3%

  • Revvity's stock saw a strong bullish movement today, rising by 6.9% ahead of the U.S. stock market open.
  • The positive market response could be attributed to the company's recent guidance hike and exceeding the top-end of its EPS and revenue guidance, indicating stronger-than-expected financial performance.
  • Investors might be optimistic about Revvity's upcoming earnings report and the anticipated financial results, with revenue expectations for the fourth quarter and full year 2025 looking promising.
  • The presentation suggesting that existing end market trends will continue into 2026 could have also contributed to the bullish sentiment surrounding Revvity's stock today.

27.01.2025 - RVTY Stock was down 5.3%

  • Options market activities indicate potential insider information or speculation impacting Revvity's performance, leading to heightened selling pressure.
  • Concerns or uncertainties regarding Revvity's future plans or financial outcomes may be influencing investors to adopt a more careful stance.
  • The stock's downturn could also stem from traders cashing in profits after benefiting from its earlier positive performance, resulting in a temporary decrease in value.

10.05.2025 - RVTY Stock was up 4.1%

  • RVTY stock experienced a strong bullish movement today, outperforming market expectations.
  • The positive market sentiment could be attributed to the company's recent product launches and strategic partnerships, driving investor confidence in its growth potential.
  • Investors are optimistic about RVTY's future earnings prospects, leading to increased buying interest and pushing the stock price higher.
  • The bullish trend indicates a favorable outlook for RVTY, with potential for further upside as market conditions remain supportive.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.